SCHEMBL29256500

SCHEMBL29256500

CCc1cc(C(O)CO)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ CYP3A4 P08684 3/20 0.40
▸ TSHR P16473 2/20 0.40
▸ PRKCI P41743 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ ACSS2 Q9NR19 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ SREBF1 P36956 1/20 0.33
▸ SREBF2 Q12772 1/20 0.33
▸ SORD Q00796 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ CDC7 O00311 1/20 0.32
▸ DBF4 Q9UBU7 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ BRD4 O60885 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29256496 1.00 CYP1A2 (0.45) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL18415133 0.81 CYP1A2 (0.47) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL11994370 0.77 CYP1A2 (0.46) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL17000203 0.74 CYP1A2 (0.43) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL19846685 0.74 CYP1A2 (0.47) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL27652629 0.74 CYP1A2 (0.43) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL28235461 0.74 CYP1A2 (0.43) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL14643122 0.74 CYP1A2 (0.43) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL20960558 0.73 CYP1A2 (0.46) CYP1A2POLBCYP3A4TSHRPRKCI
SCHEMBL19910242 0.73 CYP1A2 (0.42) CYP1A2POLBCYP3A4TSHRPRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118340754-A Compound for treating heart failure and related diseases and application thereof 源道医药(苏州)有限公司 2024-07-16 — — CN disclosed
Send feedback